No Data
SiriusXM CEO Jennifer Witz to Deliver C Space Keynote at CES 2025
Witz More Than Doubles Full-Year Profit
WITZ Corp. Reports Robust Financial Growth
Stocks that moved the previous day part1 include Shochiku, AeroEdge, Koshidaka HD, etc.
Stock name <Code> 11th closing price ⇒ Previous day comparison Shochiku <9601> 9246 -106925 Financial estimates for the fiscal year ending February 25 have been revised downward. Vitz <4440> 840 +30 Operating profit is expected to increase by 50.6% in the previous period and 19.6% in this period. Part-time Thai <2341> 143 -8 The operating profit for the first half decreased by 98.2%, expanding the decrease rate from 80.3% in the first quarter. Chordia <190A> 296 -38 At the Japan Society of Hematology Academic Meeting, the first-phase clinical trial of the CLK inhibitor CTX-712.
WITZ To Go Ex-Dividend On August 28th, 2025 With 15 JPY Dividend Per Share
October 12th (Japan Standard Time) - $WITZ(4440.JP)$ is trading ex-dividend on August 28th, 2025.Shareholders of record on August 31st, 2025 will receive 15 JPY dividend per share. The ex-dividend
Active and newly established stocks in the afternoon session.
*Matsushita <9601> 9246 -106 Lowered financial estimates for the fiscal year ending February 2025. *Vitz <4440> 840 +30 Operating profit expected to increase by 50.6% from the previous period and by 19.6% for the current period. *Albaitai <2341> 143 -8 The operating profit for the first half decreased by 98.2%, expanding the decrease rate from 80.3% in the first quarter. *Chordia <190A> 296 -38 Announcement of the results of the Phase I clinical trial of the CLK inhibitor CTX-712 at the Japan Society of Hematology Annual Meeting. *Aer
No Data
No Data